rethinkTHC Search
Menu
Study breakdown

The endocannabinoid system controls fear and pain differently depending on which part of the prefrontal cortex is involved

Animal StudyPreliminary evidence
The takeaway

Blocking or enhancing endocannabinoid signaling in different prefrontal cortex subregions had opposing effects on fear-conditioned pain suppression and freezing behavior in rats.

Pain researchers, neuroscientists, and anyone interested in how the brain's cannabinoid system processes fear and pain.

Same drug had opposite effects in infralimbic vs. prelimbic cortex

What the researchers found

The CB1 receptor antagonist AM251 attenuated fear-conditioned analgesia (FCA) when injected into the infralimbic or prelimbic cortex, but reduced freezing only in the infralimbic region. The FAAH inhibitor URB597 attenuated FCA and freezing in the infralimbic cortex but prolonged FCA in the prelimbic cortex. Neither drug had effects in the anterior cingulate cortex.

Why it matters

The endocannabinoid system is a drug target for both pain and anxiety. This study reveals that its role varies dramatically even within adjacent brain subregions, which has implications for precision medicine approaches.

The numbers in context

Three prefrontal subregions tested: infralimbic, prelimbic, anterior cingulate cortex. AM251 and URB597 had distinct, subregion-specific effects on pain suppression and fear.

How the study worked

Male rats received intra-prefrontal cortex microinjections of AM251 (CB1 antagonist), URB597 (FAAH inhibitor), or combination, then underwent formalin-evoked pain testing in a fear-conditioned arena previously paired with footshock.

What this study cannot tell us

Rat study using microinjections that do not replicate systemic cannabis use. Only male rats were tested. The pharmacological tools used (AM251, URB597) affect endocannabinoids broadly, not just anandamide.

How to read the evidence

Preliminary: animal study with microinjections into specific brain subregions.

When this study was published

Published in 2019.

The bigger picture

Cannabis affects pain and fear/anxiety, but not always in the same direction for everyone. This study shows part of the reason: even within the prefrontal cortex, the endocannabinoid system plays different and sometimes opposing roles depending on the exact location.

Questions still open

  • Do these subregion-specific effects translate to humans? Could targeted brain stimulation combined with cannabinoids produce better pain or anxiety outcomes? Why does the anterior cingulate appear uninvolved?

Common questions

What is fear-conditioned analgesia?
When an animal or person is in a fearful situation, pain sensitivity can decrease. This is called fear-conditioned analgesia and involves the endocannabinoid system.
Why does location within the prefrontal cortex matter?
Different prefrontal subregions connect to different brain circuits. The infralimbic cortex is more involved in fear extinction, while the prelimbic cortex maintains fear responses, so cannabinoid modulation has different consequences in each.

Read the original research

The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner.

British journal of pharmacology, 176(10), 1492-1505

Citation

Rea, Kieran; McGowan, Fiona; Corcoran, Louise; Roche, Michelle; Finn, David P. (2019). The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner.. British journal of pharmacology, 176(10), 1492-1505. https://doi.org/10.1111/bph.14376

Explore the wider topic